These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37409491)
1. TRIM11 expression in non-small cell lung cancer is associated with poor prognosis. Kuempers C; Jagomast T; Paulsen FO; Heidel C; Bohnet S; Schierholz S; Reischl M; Dreyer E; Olchers T; Reck M; Kirfel J; Perner S Histol Histopathol; 2024 Apr; 39(4):437-446. PubMed ID: 37409491 [TBL] [Abstract][Full Text] [Related]
2. TRIM11 promotes cell proliferation of non-small cell lung cancer through the inhibition of ferroptosis by AMPK. Liang Z; Li J; Zhang G; Chen M Clin Respir J; 2023 Oct; 17(10):1006-1016. PubMed ID: 37604203 [TBL] [Abstract][Full Text] [Related]
3. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells. Wang X; Shi W; Shi H; Lu S; Wang K; Sun C; He J; Jin W; Lv X; Zou H; Shu Y J Exp Clin Cancer Res; 2016 Jun; 35(1):100. PubMed ID: 27329103 [TBL] [Abstract][Full Text] [Related]
4. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193. Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062 [TBL] [Abstract][Full Text] [Related]
5. Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway. Wang XL; Lu SC; Sun C; Jin WG; Fan YW; Shu YS; Shi HC; Min LF Cancer Biol Ther; 2021 Apr; 22(4):324-332. PubMed ID: 33970779 [TBL] [Abstract][Full Text] [Related]
6. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53. Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611 [TBL] [Abstract][Full Text] [Related]
7. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma. Chen Y; Li L; Qian X; Ge Y; Xu G Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):190-196. PubMed ID: 28065743 [TBL] [Abstract][Full Text] [Related]
8. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. Shang M; Weng L; Xu G; Wu S; Liu B; Yin X; Mao A; Zou X; Wang Z J Cell Physiol; 2021 Oct; 236(10):6868-6883. PubMed ID: 33629745 [TBL] [Abstract][Full Text] [Related]
9. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1. Yang J; Ye J; Ma T; Tang F; Huang L; Liu Z; Tian S; Cheng X; Zhang L; Guo Z; Tu F; He M; Xu X; Lu X; Wu Y; Zeng X; Zou J; Wang X; Peng W; Zhang P Hepatology; 2022 Sep; 76(3):612-629. PubMed ID: 34767673 [TBL] [Abstract][Full Text] [Related]
10. TRIM11 promotes lymphomas by activating the β-catenin signaling and Axin1 ubiquitination degradation. Hou Y; Ding M; Wang C; Yang X; Ye T; Yu H Exp Cell Res; 2020 Feb; 387(2):111750. PubMed ID: 31786079 [TBL] [Abstract][Full Text] [Related]
11. Tripartite motif‑containing 11 regulates the proliferation and apoptosis of breast cancer cells. Dai X; Geng F; Li M; Liu M Oncol Rep; 2019 Apr; 41(4):2567-2574. PubMed ID: 30816511 [TBL] [Abstract][Full Text] [Related]
12. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554 [TBL] [Abstract][Full Text] [Related]
13. TRIM11 stimulates the proliferation of gastric cancer through targeting CPEB3/EGFR axis. Luo N; Wang Z J BUON; 2020; 25(4):2097-2104. PubMed ID: 33099959 [TBL] [Abstract][Full Text] [Related]
14. TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells. Zhao Z; Deng J; Lu M; Yang J; Chen L; Li D; Sang Y Mol Biol Rep; 2023 Jan; 50(1):731-737. PubMed ID: 36376537 [TBL] [Abstract][Full Text] [Related]
15. CDK7 is a prognostic biomarker for non-small cell lung cancer. Kuempers C; Jagomast T; Heidel C; Paulsen FO; Bohnet S; Schierholz S; Dreyer E; Kirfel J; Perner S Front Oncol; 2022; 12():927140. PubMed ID: 36212402 [TBL] [Abstract][Full Text] [Related]
16. LncRNA LUADT1 is Upregulated in Mantle Cell Lymphoma and Modulates TRIM11 by Sponging miR-24-3p to Inhibit Cell Apoptosis. Dong L; Zhang H; Zan T; Han J; Xue Q; Sun Y Crit Rev Eukaryot Gene Expr; 2021; 31(5):33-40. PubMed ID: 34591388 [TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma]. Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928 [TBL] [Abstract][Full Text] [Related]
18. TRIM11 promotes tumor angiogenesis via activation of STAT3/VEGFA signaling in lung adenocarcinoma. Huang J; Tang L; Zhao Y; Ding W Am J Cancer Res; 2019; 9(9):2019-2027. PubMed ID: 31598402 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of tripartite motif protein 11 attenuates cardiomyocyte apoptosis after ischemia/reperfusion injury via DUSP1-JNK1/2. He F; Wu Z; Wang Y; Yin L; Lu S; Dai L Cell Biol Int; 2022 Jan; 46(1):148-157. PubMed ID: 34694031 [TBL] [Abstract][Full Text] [Related]
20. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer. Tang J; Tian Z; Liao X; Wu G Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]